Woops forgot to reply, yeah they linked a few SNPs to the responsiveness to pgd2 but haven't fine tuned exactly how. Might give an indication but definitely not an accurate prediction if you've had your genes sequenced.
If you've done a test, check any of these:
rs545659 - CT or CC => likely PGD2-sensitive, TT => likely PGD2-insensitive
rs634681 - AG or AA => likely PGD2-sensitive, GG => likely PGD2-insensitive
rs7167 - AG or GG => likely PGD2-sensitive, AA => likely PGD2-insensitive
TRANSLATION:
likely PGD2-sensitive => 64.1% chance of PGD2 sensitivity
likely PGD2-insensitive => 36.5% chance of PGD2 sensitivity
Thanks. I was reading the patent this morning, and I am unlikely to be a responder. I don't know about the third, but on the first two I'm homozygous for the major allele.
It's good to see you around again. While you're here, what do you think about the latest Follica patent? They are coming back again to EGFR inhibition after wounding. EGF is important for HF cyclying. Do you think it's a good idea to inhibit it for 7-10 days post-wounding while morphogenesis occurs?
Last edited: